α1‐Adrenergic effects and liver regeneration

• Published in: Hepatology (Baltimore, Md.) Md.), 1987-11, Vol.7 (6), p.1189-1194
• Main Authors: Cruise, Jennifer L., Knechtle, Stuart J., Bollinger, R. Randal, Kuhn, Cynthia, Michalopoulos, George
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Digestive system; Medical sciences; Pharmacology. Drug treatments
• ISSN: 0270-9139; 1527-3350
• DOI: 10.1002/hep.1840070604

The effects of several treatments involving α‐adrenergic mechanisms upon the early stages of rat liver regeneration were examined. Catecholamine concentrations in rat plasma were measured at various times after hepatectomy and were found to be elevated relative to those in plasma from sham‐operated rats. Surgical hepatic denervation or injection of an α1‐adrenergic receptor antagonist (prazosin) reduced incorporation of [3H] thymidine into liver DNA during the first 24 hr after partial hepatectomy. Chronic guanethidine injections (3 to 6 weeks) reduced liver catecholamine levels, but did not affect its ability to regenerate. The inhibition of regenerative DNA synthesis by prazosin was preceded by an alteration in the binding of epidermal growth factor to regenerating liver, which was apparently the result of an increased number of epidermal growth factor receptors. Thus, α1‐adrenergic blockade, which affects both epidermal growth factor receptor binding and subsequent DNA synthesis in hepatocyte primary cultures, can also modulate these processes during liver regeneration in vivo.